The $8 million seed was co-led by Sequoia Capital and First Round Capital, and the $30 million Series A was led by Hummingbird Ventures. The total is $38 million, and valuation is not disclosed. The company began with a nutrition tool for dietitians and later moved to a broader platform for hospitalized patients.

The platform is deployed in more than 50 hospitals. It plugs into hospital electronic health records, pulls signals from written notes, and feeds structured data into risk models. Each night it analyzes adult inpatient records, and each morning it writes a risk score into the care team's workflow. The software highlights items for review rather than diagnosing patients.

The round is read as a bet on EHR plumbing, not on a named model. What buyers need is clinical trust, not compute. A 5x hard ROI claim appears in the article, but it is a company claim tied to finance attribution.

Validation results for aspiration pneumonia, pressure ulcers, and congestive heart failure readmission are not included. TechCrunch supplies hospital names and ROI claims, but no independent audit of the risk score appears in the packet. No page measures sensitivity, specificity, false-positive rate, or clinician override rate. Exact revenue, per-bed price, condition count, and model architecture remain unmeasured.

Treat the round as an EHR plumbing bet; withhold claims about harm reduction until validation and audit appear.